Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 1998

View Archived Issues

Neurokinin A: a peptide with a potential role in the perception of pain

Novel PDE IV inhibitors in the pipeline at Jouveinal/Parke-Davis

Discovery Laboratories begins phase Ib trials of ST-630

Genta announces issue of patent for lead antisense compound

Transkaryotic Therapies receives patent for Gene Activation technology

Zadaxin in combination with TACE shows promise in liver cancer therapy

Warner-Lambert announces collaboration with Forest

Advisory committee meeting scheduled for atosiban NDA review

Biora highlights progress of product pipeline at recent meeting

Targeted Genetics and Copernicus Gene Systems announce collaborative research agreement

HBOC-201 reduces need for blood transfusions in surgery

Celtrix reports interim results of phase II clinical study of SomatoKine

Gilead broadens HIV expanded access program for Preveon

Study shows Quadramet provides significant relief from bone pain

New factor Xa inhibitors designed at DuPont Merck

Factor Xa inhibitor selected for clinical trials at Berlex Biosciences

Forest, Lundbeck form strategic alliance for CNS drugs

Abbott discovers new agents for controlling synaptic transmission

Advisory committee meeting cancellation announced

Fournier claims new bradykinin antagonists

Ro-25-3036 improves dosing frequency of IFN in hepatitis patients

HER2 receptor tyrosine kinase inhibitors synthesized at Takeda

Heparinase I pharmacokinetics evaluated in healthy volunteers

Aspartame has potent antiarthritic activity in preclinical models and arthritic subjects

IntraBiotics develops novel cyclic peptide antimicrobials

Symphar antineoplastic agent induces apoptosis and reverses MDR

Schering-Plough and Centocor announce international licensing agreement for Avakine

Novel topoisomerase I inhibitor discovered at Kaken

Baxter, Inhale select lead compound for further development

Expanded indication approved for Proscar

Sonus completes enrollment in EchoGen emulsion phase III prostate imaging trial

Viracept introduced by Roche in most of Japan